Articles related to Nephrology

Recent evidence suggests that the initiation of treatment with thiazide diuretics carries a more substantial risk for hyponatremia than previously recognized, particularly in the initial months of treatment.

Belzutifan’s FDA approval, following the LITESPARK-005 trial results, represents a significant stride in treating advanced kidney cancer, offering a novel therapeutic option for patients who have exhausted standard treatments.

In the delicate dance of AI and healthcare, a sobering revelation surfaces—predictive models, designed to enhance accuracy in ICU predictions, may inadvertently compromise their own efficacy.

A recent case of a 38-year-old man with end-stage renal disease highlighted the rare but significant complication of quadriceps tendon rupture, often associated with chronic kidney disease and secondary hyperparathyroidism.

A recent case study stresses the importance of considering Addison disease in patients presenting with long-standing hyperpigmentation. Notably, the patient’s potassium level was found to be 5.7 mmol/L (reference range 3.6–4.8) at admission.

The approval of empagliflozin opens up a new avenue in CKD treatment. With its proven efficacy in reducing the risk of disease progression by 28%, it offers a promising alternative for healthcare professionals dealing with this prevalent condition.